Forrest v. Par Pharmaceutical, Inc.

46 F. Supp. 2d 244, 1999 U.S. Dist. LEXIS 5888, 1999 WL 239924
CourtDistrict Court, S.D. New York
DecidedApril 22, 1999
Docket98 Civ. 5594(BDP)
StatusPublished

This text of 46 F. Supp. 2d 244 (Forrest v. Par Pharmaceutical, Inc.) is published on Counsel Stack Legal Research, covering District Court, S.D. New York primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Forrest v. Par Pharmaceutical, Inc., 46 F. Supp. 2d 244, 1999 U.S. Dist. LEXIS 5888, 1999 WL 239924 (S.D.N.Y. 1999).

Opinion

MEMORANDUM DECISION AND ORDER

BARRINGTON D. PARKER, Jr., District Judge.

Plaintiff Christopher H. Forrest sued his employer, Par Pharmaceutical, Inc. (“Par”), alleging race discrimination. See 42 U.S.C. § 2000e et seq. Par now moves to disqualify plaintiff Forrest’s counsel, Kevin Mulhearn, Esq., on the ground that he is a key witness to material events. See N.Y.Comp.Codes R. & Regs. tit. 22, § 1200.21(b) (1998), Model Code of Professional Responsibility DR 5-102(b) (1980). For the reasons stated, the motion is denied.

BACKGROUND

From 1990 to April 6, 1998, Forrest was employed by Par in its Quality Assurance Department. Forrest was responsible for *246 making and maintaining entries in a logbook tracking the movements of controlled substances into and out of Par’s controlled substances vault.

On October 22, 1997, plaintiff filed a complaint against Par with the New York State Division of Human Rights alleging various incidents of race discrimination. On May 13, 1998, the Division of Human Rights issued Forrest a Notice of Right to Sue and on July 15, 1998, he commenced this action.

On February 2, 1998, while plaintiff was still employed by Par, Par received a complaint from a distributor complaining that it had purchased what it believed to be a package of ten bottles of triazolam tablets, a controlled substance used to treat insomnia. Instead of receiving ten bottles, the distributor claimed to have received nine bottles of triazolam and one bottle of cap-topril, an ACE inhibitor used to treat hypertension. As a result of the complaint, Par commenced an internal investigation and determined that the controlled substances vault logbook contained a number of apparently erroneous entries. In addition, one of the entries for the triazolam lot in question appeared to bear Forrest’s signature which appeared to have been altered. This discovery led to numerous other questions concerning entries Forrest had allegedly made, failed to make, or improperly changed.

As a consequence of Par’s discovery, on February 4, 1998, Par’s President, Kenneth Sawyer, interviewed Forrest. Forrest was unable to explain the logbook entries to Sawyer’s satisfaction and was subsequently suspended with pay while the investigation continued. On February 5, Mulhearn sent Sawyer a letter stating that it was Forrest’s belief that Par’s allegations were merely attempts to “distort his record and performance in view of his pending legal action” against Par. Also on February 5, Sawyer sent Forrest a letter offering him an opportunity to “supplement, modify or change” the substance of his verbal statements from the previous day’s interview. In a subsequent letter to Sawyer dated February 6, apparently responding to Sawyer’s February 5 offer to Forrest, Mulhearn stated:

You attribute certain entries made in the controlled substance vault reconciliation book to Mr. Forrest. Yet Mr. Forrest told you on Wednesday, February 4, 1998, and hereby affirms, that he did not make the entry corrections in question. He stated, and hereby affirms, that the signature in question is not his; and he stated, and hereby affirms, that he did not make the date entry for the subject correction in said logbook.

In a letter dated February 10, 1998, Par’s attorney, Roger Kaplan, Esq., retained in connection with Forrest’s race discrimination suit, responded to Mul-hearn’s letter. Kaplan requested an affidavit from Forrest affirming that he had not made certain logbook entries and that someone else had made the entries to appear to be Forrest’s. Mulhearn thereafter sent Kaplan an unexecuted draft affidavit which stated that Forrest had “no independent recollection” of making, initialing or dating the logbook entries and that the entries do “not appear to be in my [Forrest’s] handwriting, and are written differently from how I normally write.”

Citing differences in syntax between Mulhearn’s February 6 letter and Forrest’s unexecuted affidavit, Kaplan phoned Mulhearn on February 24, 1998 and requested that the affidavit be redrafted to contain language similar to that of the February 6 letter. Mulhearn initially agreed, but called back that same day and refused to make the changes. Par now contends that Mulhearn claimed “perjury concerns” for not modifying the affidavit.

Mulhearn, on the other hand contends in his Affirmation in response to Par’s Motion to Disqualify that he did not want opposing counsel to serve as a draftsman for an affidavit for Mulhearn’s client, and that Mulhearn was concerned about including an absolute denial in an affidavit that *247 concerned events that had occurred months earlier and involved routine and frequently repeated activities. Mulhearn also contends that he told Kaplan during the second February 24 phone conversation “that [he] did not want [his] client to make unequivocal statements that might later prove to be untrue in view of the fact that th[e] affidavit contained testimony sworn to under penalties of perjury.”

On November 25, 1998, Par moved to disqualify Mulhearn pursuant to DR 5-102(b) on the ground that it intends to call Mulhearn as a “key witness” to help establish that Forrest’s termination was for a proper business purpose and not in retaliation for his discrimination claim. Par also seeks Mulhearn’s testimony concerning plaintiffs alleged “midcourse correction” resulting in differing language in the February 6 letter and the subsequent unexe-cuted affidavit. Par contends that the unequivocal denials of wrongdoing made by Mulhearn on behalf of Forrest in the February 6 letter are inconsistent with the language of Forrest’s unexecuted affidavit denying any “independent recollection” of making the suspect entries. Finally, Par intends to call Mulhearn to testify about Forrest’s attempt to tape-record the March 26 meeting with Par representatives.

DISCUSSION

Our Circuit recognizes the New York Code of Professional Responsibility as prescribing appropriate guidelines for professional conduct. See NCK Org. Ltd. v. Bregman, 542 F.2d 128, 129 n. 2 (2d Cir.1976). Motions to disqualify an attorney under DR 5 — 102(b), however, are subject to disfavor and to strict scrutiny because of their potential for abuse. See Parke-Hayden, Inc. v. Loews Theatre Management Corp., 794 F.Supp. 525, 527 (S.D.N.Y.1992) (quoting Lamborn v. Dittmer, 873 F.2d 522, 531 (2d Cir.1989)). Specifically, “[disqualification motions premised upon the advocate-witness rule are subjected to strict scrutiny because of the ‘strong potential for abuse when a lawyer invokes the need to call opposing counsel as a witness and then acts to disqualify him as counsel.” Paramount Communications, Inc. v. Donaghy, 858 F.Supp. 391, 394 (S.D.N.Y.1994) (citing Russo v. Friedman, 91 Civ. 6913, 1992 WL 196791, 1992 U.S. Dist. LEXIS 11418 (S.D.N.Y. July 31, 1992)). See Clark v. Bank of New York, 801 F.Supp.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Rice v. Baron
456 F. Supp. 1361 (S.D. New York, 1978)
Parke-Hayden, Inc. v. Loews Theatre Management Corp.
794 F. Supp. 525 (S.D. New York, 1992)
Clark v. Bank of New York
801 F. Supp. 1182 (S.D. New York, 1992)
Paramount Communications, Inc. v. Donaghy
858 F. Supp. 391 (S.D. New York, 1994)
S & S Hotel Ventures Limited Partnership v. 777 S. H. Corp.
508 N.E.2d 647 (New York Court of Appeals, 1987)
Kupplungsbau GmbH v. Lerner
167 A.D.2d 451 (Appellate Division of the Supreme Court of New York, 1990)
Kirshon, Shron, Cornell & Teitelbaum v. Savarese
182 A.D.2d 911 (Appellate Division of the Supreme Court of New York, 1992)

Cite This Page — Counsel Stack

Bluebook (online)
46 F. Supp. 2d 244, 1999 U.S. Dist. LEXIS 5888, 1999 WL 239924, Counsel Stack Legal Research, https://law.counselstack.com/opinion/forrest-v-par-pharmaceutical-inc-nysd-1999.